Skip to content

The effect of the Nutrition-Care Gluco-Metabolism Formula on glucose levels in pre-diabetic adults: The Gluco-Metabolism Trial

Randomised double-blinded placebo-controlled trial of 12 weeks duration investigating the tolerability and effectiveness of the Nutrition-Care Gluco-Metabolism Formula on glucose control in pre-diabetic adults.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001357145
Enrollment
60
Registered
2019-10-03
Start date
2019-10-08
Completion date
2020-04-30
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Prevention and early diagnosis of diabetes is key to avoid diabetes-related complications. In 2018, 2 million Australians are estimated to have pre-diabetes and are at high-risk of developing type 2 diabetes. The Nutrition-Care Gluco-Metabolism Formula contains a mixture of herbs and nutrients, which have been shown to be beneficial for balancing blood glucose levels in the blood. In this randomised double-blind placebo-controlled 12-week trial we aim to assess the tolerability and efficacy of the Gluco-Metabolism Formula for glucose control in pre-diabetics.

Interventions

Randomised double-blind placebo-controlled trial of 12 weeks duration investigating the effect and tolerability of the Nutrition-Care Gluco-Metabolism-Herbal Formula on glucose levels in pre-diabetic adults. The intervention will comprise of 2x3 Gluco-Metabolism tablets (active group) or placebo (control group) daily for 12 weeks. The active tablets contain a gymnema silvestre, cinnamon cassia, bitter melon, fenugreek, nigella sativa, portulaca oleracea, alpha-lipoic acid, chromium picolinate,

Randomised double-blind placebo-controlled trial of 12 weeks duration investigating the effect and tolerability of the Nutrition-Care Gluco-Metabolism-Herbal Formula on glucose levels in pre-diabetic adults. The intervention will comprise of 2x3 Gluco-Metabolism tablets (active group) or placebo (control group) daily for 12 weeks. The active tablets contain a gymnema silvestre, cinnamon cassia, bitter melon, fenugreek, nigella sativa, portulaca oleracea, alpha-lipoic acid, chromium picolinate, and biotin. Daily dosage is 25g/ day. Compliance will be assessed by returned tablet count at 4-weekly visits.

Sponsors

AProf Dr Karin Ried
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1) Pre-diabetes: FPG: 5.5-7.0 mmol/l and/or PPG: 7.8-11.1 mmol/l Assessment done with Accu-Chek Mobile Blood Glucose Meter (Roche) & disposable strips

Exclusion criteria

Diagnosed with diabetes, on diabetic medication (e.g. insulin, metformin) or glucose control supplements Diagnosed with chronic illness (cancer, non-fatty-liver), or pregnancy or breastfeeding Taking vitamin C supplements or IVC, and not willing to stop for the length of the trial (as vitamin c can falsify plasma glucose readings) If FPG or PPG are in the diabetic range during screening, the volunteer won’t be eligible to participate in the trial, and will be referred to a GP for follow-up. Have had recent surgery, or planning on any surgery, or change of medication during the 3-4 month study Intolerance or allergies to ingredients in Gluco-Metabolism formula

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026